<SEC-DOCUMENT>0001564590-19-013577.txt : 20190429
<SEC-HEADER>0001564590-19-013577.hdr.sgml : 20190429
<ACCEPTANCE-DATETIME>20190429124425
ACCESSION NUMBER:		0001564590-19-013577
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20190423
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20190429
DATE AS OF CHANGE:		20190429

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			IRIDEX CORP
		CENTRAL INDEX KEY:			0001006045
		STANDARD INDUSTRIAL CLASSIFICATION:	ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
		IRS NUMBER:				770210467
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1229

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-27598
		FILM NUMBER:		19774836

	BUSINESS ADDRESS:	
		STREET 1:		1212 TERRA BELLA AVE
		CITY:			MOUNTAIN VIEW
		STATE:			CA
		ZIP:			94043
		BUSINESS PHONE:		6509404700

	MAIL ADDRESS:	
		STREET 1:		1212 TERRA BELLA AVENUE
		CITY:			MOUNTAIN VIEW
		STATE:			CA
		ZIP:			94043
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>irix-8k_20190423.htm
<DESCRIPTION>8-K
<TEXT>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
<head>
<title>
irix-8k_20190423.DOCX.htm
</title>
</head>
<!-- NG Converter v5.0.19114.148 -->
<body>

<p style="margin-top:0pt;margin-bottom:0pt;text-indent:7.69%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:468pt;;">
<tr>
<td style="width:130.5pt;"></td>
<td style="width:0.9pt;"></td>
<td style="width:24.6pt;"></td>
<td style="width:156pt;"></td>
<td style="width:30pt;"></td>
<td style="width:0.9pt;"></td>
<td style="width:125.1pt;"></td>
</tr>
<tr>
<td colspan="7" valign="top" >
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;margin-left:0pt;;;font-size:16pt;letter-spacing:0pt;font-weight:bold;letter-spacing:-0.2pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;text-indent:36pt;;">UNITED STATES<br />SECURITIES AND EXCHANGE COMMISSION</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;margin-left:0pt;;text-indent:36pt;;font-size:10pt;font-weight:bold;letter-spacing:-0.1pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Washington, D.C. 20549</p></td>
</tr>
<tr>
<td colspan="7" valign="top" >
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;margin-left:0pt;;text-indent:36pt;;font-weight:bold;font-size:11pt;letter-spacing:-0.1pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"></p></td>
</tr>
<tr>
<td colspan="7" valign="top" >
<p style="margin-top:3pt;text-align:center;margin-bottom:0pt;margin-left:0pt;;text-indent:36pt;;font-size:16pt;letter-spacing:0pt;font-weight:bold;letter-spacing:-0.2pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">FORM 8&#8209;K</p>
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;margin-left:0pt;;text-indent:36pt;;font-size:12pt;letter-spacing:0pt;font-weight:bold;letter-spacing:-0.2pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">CURRENT REPORT</p></td>
</tr>
<tr>
<td colspan="7" valign="top" >
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;margin-left:0pt;;text-indent:36pt;;font-weight:bold;font-size:11pt;letter-spacing:-0.1pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"></p></td>
</tr>
<tr>
<td colspan="7" valign="middle" >
<p style="margin-top:6pt;text-align:center;margin-bottom:0pt;margin-left:0pt;;text-indent:36pt;;font-size:11pt;letter-spacing:0pt;font-weight:bold;letter-spacing:-0.15pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">PURSUANT TO SECTION 13 OR 15(d) OF THE<br />SECURITIES EXCHANGE ACT OF 1934</p></td>
</tr>
<tr>
<td valign="top" >
<p style="margin-top:6pt;text-align:center;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:bold;">&nbsp;</p></td>
<td colspan="4" valign="top" >
<p style="margin-top:6pt;text-align:center;margin-bottom:0pt;margin-left:0pt;;text-indent:36pt;;font-size:10pt;letter-spacing:0pt;font-weight:bold;letter-spacing:-0.1pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">April 23, 2019</p></td>
<td colspan="2" valign="top" >
<p style="text-align:left;margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:bold;">&nbsp;</p></td>
</tr>
<tr>
<td colspan="7" valign="top" >
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;margin-left:0pt;;text-indent:36pt;;letter-spacing:0pt;font-weight:bold;font-size:8pt;letter-spacing:-0.1pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Date of Report (date of earliest event reported)</p></td>
</tr>
<tr>
<td colspan="7" valign="top" >
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;margin-left:0pt;;text-indent:36pt;;font-weight:bold;font-size:11pt;letter-spacing:-0.1pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"></p></td>
</tr>
<tr>
<td colspan="7" valign="top" >
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;margin-left:0pt;;text-indent:36pt;;font-size:22pt;letter-spacing:0pt;font-weight:bold;letter-spacing:-0.2pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">IRIDEX CORPORATION</p></td>
</tr>
<tr>
<td colspan="7" valign="top" >
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;margin-left:0pt;;text-indent:36pt;;letter-spacing:0pt;font-weight:bold;font-size:8pt;letter-spacing:-0.1pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Exact name of registrant as specified in its charter)</p></td>
</tr>
<tr>
<td colspan="7" valign="top" >
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;margin-left:0pt;;text-indent:36pt;;font-weight:bold;font-size:11pt;letter-spacing:-0.1pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"></p></td>
</tr>
<tr>
<td colspan="3" valign="top" >
<p style="margin-top:6pt;text-align:center;margin-bottom:0pt;margin-left:0pt;;text-indent:36pt;;font-size:10pt;letter-spacing:0pt;font-weight:bold;letter-spacing:-0.1pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Delaware</p></td>
<td valign="top" >
<p style="margin-top:6pt;text-align:center;margin-bottom:0pt;margin-left:0pt;;text-indent:36pt;;font-size:10pt;letter-spacing:0pt;font-weight:bold;letter-spacing:-0.1pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">0-27598</p></td>
<td colspan="3" valign="top" >
<p style="margin-top:6pt;text-align:center;margin-bottom:0pt;margin-left:0pt;;text-indent:36pt;;font-size:10pt;letter-spacing:0pt;font-weight:bold;letter-spacing:-0.1pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">77-0210467</p></td>
</tr>
<tr>
<td colspan="3" valign="top" >
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;margin-left:0pt;;text-indent:36pt;;letter-spacing:0pt;font-weight:bold;font-size:8pt;letter-spacing:-0.1pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(State or other jurisdiction of<br />incorporation or organization)</p></td>
<td valign="top" >
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;margin-left:0pt;;text-indent:36pt;;letter-spacing:0pt;font-weight:bold;font-size:8pt;letter-spacing:-0.1pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Commission File Number)</p></td>
<td colspan="3" valign="top" >
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;margin-left:0pt;;text-indent:36pt;;letter-spacing:0pt;font-weight:bold;font-size:8pt;letter-spacing:-0.1pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(I.R.S. Employer<br />Identification Number)</p></td>
</tr>
<tr>
<td colspan="7" valign="top" >
<p style="margin-top:6pt;text-align:center;margin-bottom:0pt;margin-left:0pt;;text-indent:36pt;;font-size:10pt;letter-spacing:0pt;font-weight:bold;letter-spacing:-0.1pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">1212 Terra Bella Avenue<br />Mountain View, California 94043</p></td>
</tr>
<tr>
<td colspan="7" valign="top" >
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;margin-left:0pt;;text-indent:36pt;;letter-spacing:0pt;font-weight:bold;font-size:8pt;letter-spacing:-0.1pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Address of principal executive offices, including zip code)</p></td>
</tr>
<tr style="height:20.25pt;">
<td colspan="2" valign="top" >
<p style="margin-top:6pt;text-align:center;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-family:Times New Roman;font-weight:bold;">&nbsp;</p></td>
<td colspan="4" valign="top" >
<p style="margin-top:6pt;text-align:center;margin-bottom:0pt;margin-left:0pt;;text-indent:36pt;;font-size:10pt;letter-spacing:0pt;font-weight:bold;letter-spacing:-0.1pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(650) 940-4700</p></td>
<td valign="top" >
<p style="margin-top:6pt;text-align:center;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:bold;">&nbsp;</p></td>
</tr>
<tr style="height:11.65pt;">
<td colspan="2" valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:8pt;font-weight:bold;">&nbsp;</p></td>
<td colspan="4" valign="top" >
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;margin-left:0pt;;text-indent:36pt;;font-size:8pt;letter-spacing:0pt;font-weight:bold;letter-spacing:-0.1pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Registrant&#8217;s telephone number, including area code)</p></td>
<td valign="top" >
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-weight:bold;">&nbsp;</p></td>
</tr>
<tr style="height:20.25pt;">
<td colspan="7" valign="top" >
<p style="margin-top:12pt;text-align:center;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:11pt;font-weight:bold;">&nbsp;</p></td>
</tr>
<tr style="height:11.65pt;">
<td colspan="7" valign="top" >
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;margin-left:0pt;;text-indent:36pt;;font-size:8pt;letter-spacing:0pt;font-weight:bold;letter-spacing:-0.1pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Former name or former address, if changed since last report)</p></td>
</tr>
<tr>
<td colspan="7" valign="top" >
<p style="text-align:center;margin-top:12pt;margin-bottom:0pt;margin-left:0pt;;text-indent:36pt;;font-weight:bold;font-size:11pt;letter-spacing:-0.1pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"></p></td>
</tr>
<tr>
<td colspan="7" valign="top" >
<p style="text-align:left;margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;text-indent:36pt;;font-weight:normal;font-size:11pt;letter-spacing:-0.1pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): </p></td>
</tr>
<tr>
<td colspan="7" valign="top" >
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:22.3pt;;margin-right:0.21%;text-indent:-22.3pt;;font-size:10.5pt;letter-spacing:-0.1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="Check1"></a><font style="font-size:10.5pt;letter-spacing:-0.1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="Check1"></a>&#9744;</font><font style="font-size:11pt;"></font><font style="font-weight:bold;font-size:11pt;"></font><font style="font-size:11pt;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</font></p></td>
</tr>
<tr>
<td colspan="7" valign="top" >
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:22.3pt;;margin-right:0.21%;text-indent:-22.3pt;;font-size:10.5pt;letter-spacing:-0.1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10.5pt;letter-spacing:-0.1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#9744;</font><font style="font-size:11pt;"></font><font style="font-weight:bold;font-size:11pt;"></font><font style="font-size:11pt;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</font></p></td>
</tr>
<tr>
<td colspan="7" valign="top" >
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:22.3pt;;margin-right:0.21%;text-indent:-22.3pt;;font-size:10.5pt;letter-spacing:-0.1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="Check3"></a><font style="font-size:10.5pt;letter-spacing:-0.1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="Check3"></a>&#9744;</font><font style="font-size:11pt;"></font><font style="font-weight:bold;font-size:11pt;"></font><font style="font-size:11pt;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</font></p></td>
</tr>
<tr>
<td colspan="7" valign="top" >
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:22.3pt;;margin-right:0.21%;text-indent:-22.3pt;;font-size:10.5pt;letter-spacing:-0.1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="font-size:10.5pt;letter-spacing:-0.1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#9744;</font><font style="font-size:11pt;"></font><font style="font-size:11pt;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</font></p></td>
</tr>
<tr>
<td colspan="7" valign="top" >
<p style="margin-top:3pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0.21%;text-indent:0pt;;font-size:11pt;">&nbsp;</p></td>
</tr>
<tr>
<td colspan="7" valign="top" >
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0.21%;text-indent:0pt;;font-size:10pt;letter-spacing:-0.2pt;letter-spacing:-0.1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p></td>
</tr>
<tr>
<td colspan="7" valign="top" >
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0.21%;text-indent:0pt;;font-size:10pt;letter-spacing:0pt;letter-spacing:-0.1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Emerging growth company&nbsp;&nbsp;<font style="font-size:11pt;font-family:'Times New Roman';">&#9744;</font><font style="font-size:11pt;"></font></p></td>
</tr>
<tr>
<td colspan="7" valign="top" >
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:0pt;;margin-right:0.21%;text-indent:0pt;;font-size:10pt;letter-spacing:0pt;letter-spacing:-0.1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&nbsp;&nbsp;<font style="font-size:11pt;font-family:'Times New Roman';">&#9744;</font><font style="font-size:11pt;"></font></p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse;  margin-left:0.64%;width:112.8%;"></table></div>
<p style="margin-top:12pt;margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;text-indent:36pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse;  margin-left:0.64%;width:112.8%;">
<tr>
<td style="width:10.95%;"></td>
<td style="width:101.85%;"></td>
</tr>
<tr>
<td style="width:10.95%;"></td>
<td style="width:101.85%;"></td>
</tr>
<tr>
<td valign="top"  style="padding-Top:0pt;padding-Bottom:0pt;">
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU2"></a><font style="font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Item </font><font style="font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">5.0</font><font style="font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2</font><font style="font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">.</font></p></td>
<td valign="top"  style="padding-Top:0pt;padding-Bottom:0pt;">
<p style="text-align:justify;margin-top:0pt;margin-bottom:0pt;margin-left:15pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</p>
<p style="text-align:justify;margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td>
</tr>
</table></div>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">(d)&nbsp;&nbsp;Appointment of Directors </p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:3.42%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On April 23, 2019, the Company appointed Scott Shuda to the board of directors (the &#8220;Board&#8221;) of Iridex Corporation (the &#8220;Company&#8221;), effective April 23, 2019 (the &#8220;Effective Date&#8221;).&nbsp;&nbsp;In connection with Mr. Shuda&#8217;s appointment to the Board the size of the Board was increased from seven to eight members as of the Effective Date. </p>
<p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:3.42%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Mr. Shuda will receive standard compensation available to non-employee members of the Board and committees of the Board and each will receive an option to purchase 15,000 shares of the Company&#8217;s common stock which vests in <font style="color:#000000;">equal monthly installments over four years following the effective date of the grant.&nbsp;&nbsp;In addition, it is expected that Mr. Shuda will execute the Company&#8217;s standard form of indemnification agreement.&nbsp;&nbsp;</font></p>
<p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:3.42%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Mr. Shuda has been a member of the Board of Directors of InfuSystem Holdings, Inc. (&#8220;InfuSystem&#8221;), a provider of ambulatory infusion pumps, since September 2016, and was elected Chairman of the Board of InfuSystem in December 2018. Mr. Shuda is a Managing Director and Co-founder of Meridian OHC Partners, LP (&#8220;Meridian&#8221;) and BlueLine Partners, LLC (&#8220;BlueLine&#8221;), investment firms that focus on publicly listed technology and healthcare companies. Mr. Shuda previously served on our Board, from December 2012 to April 2017. Mr. Shuda holds both a Juris Doctor degree and a Masters of Business Administration degree from Georgetown University.</p>
<p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:3.42%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Mr. Shuda has extensive experience with the medical devices industry. He brings more than 20 years of professional experience in law, technology and entrepreneurial endeavors in the industry, including transactions that range from initial public offerings and venture financings to mergers and acquisitions. </p>
<p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:3.42%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">There are no arrangements or understandings between Mr. Shuda and any other person pursuant to which Mr. Shuda was elected as director of the Company.&nbsp;&nbsp;There are no family relationships between Mr. Shuda and any director or executive officer of the Company, and, other than as described above, no transactions involving Mr. Shuda that would require disclosure under Item 404(a) of Regulation S-K.</p>
<p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:3.57%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company&#8217;s press release dated April 29, 2019 regarding Mr. Shuda&#8217;s appointments is attached hereto as Exhibit 99.1 and is incorporated herein by reference.</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse;  margin-left:0.6%;width:103.54%;">
<tr>
<td style="width:12.5%;"></td>
<td style="width:91.04%;"></td>
</tr>
<tr>
<td valign="middle"  style="padding-Top:0pt;padding-Bottom:0pt;">
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="middle"  style="padding-Top:0pt;padding-Bottom:0pt;">
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="padding-Top:0pt;padding-Bottom:0pt;">
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Item 9.01.</p></td>
<td valign="top"  style="padding-Top:0pt;padding-Bottom:0pt;">
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Financial Statements and Exhibits. </p></td>
</tr>
</table></div>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-size:6pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse;  margin-left:0.6%;width:100%;">
<tr>
<td style="width:3.7%;"></td>
<td style="width:96.3%;"></td>
</tr>
<tr>
<td valign="middle"  style="padding-Top:0pt;padding-Bottom:0pt;">
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
<td valign="middle"  style="padding-Top:0pt;padding-Bottom:0pt;">
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;">&nbsp;</p></td>
</tr>
<tr>
<td valign="top"  style="padding-Top:0pt;padding-Bottom:0pt;">
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(d)</p></td>
<td valign="top"  style="padding-Top:0pt;padding-Bottom:0pt;">
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exhibits </p></td>
</tr>
</table></div>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-size:12pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:100%;">
<tr>
<td style="width:7.71%;"></td>
<td style="width:6.7%;"></td>
<td style="width:85.6%;"></td>
</tr>
<tr>
<td valign="bottom"  style="padding-Top:0pt;padding-Bottom:0pt;">
<p style="text-align:center;margin-top:0pt;border-bottom:Solid 0.75pt #000000;padding-bottom:0pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exhibit No.</p></td>
<td valign="bottom"  style="padding-Top:0pt;padding-Bottom:0pt;">
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  style="padding-Top:0pt;padding-Bottom:0pt;">
<p style="margin-top:0pt;border-bottom:Solid 0.75pt #000000;padding-bottom:0pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Description</p></td>
</tr>
<tr style="height:6pt;">
<td valign="middle"  style="padding-Top:0pt;padding-Bottom:0pt;">
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="middle"  style="padding-Top:0pt;padding-Bottom:0pt;">
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top"  style="padding-Top:0pt;padding-Bottom:0pt;">
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10.1*</p></td>
<td valign="bottom"  style="padding-Top:0pt;padding-Bottom:0pt;">
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top"  style="padding-Top:0pt;padding-Bottom:0pt;">
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="http://www.sec.gov/Archives/edgar/data/1006045/000156459016021155/irix-8k_20160708.htm"><font style="text-decoration:underline;">Form of Indemnification Agreement between the Company and its directors and officers.</font></a> </p></td>
</tr>
<tr>
<td valign="top"  style="padding-Top:0pt;padding-Bottom:0pt;">
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">99.1</p></td>
<td valign="bottom"  style="padding-Top:0pt;padding-Bottom:0pt;">
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td>
<td valign="top"  style="padding-Top:0pt;padding-Bottom:0pt;">
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="irix-ex991_7.htm"><font style="text-decoration:underline;">Press Release dated April 29, 2019.</font></a></p></td>
</tr>
</table></div>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">* Incorporated by reference to the Exhibits filed with the Registrant&#8217;s Report on Form 8-K on July 11, 2016.</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-size:12pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-size:12pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></p>
<p style="text-align:center;margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;;font-size:10pt;"><a name="_AEIOULastRenderedPageBreakAEIOU4"></a>&nbsp;</p>
<p style="text-align:center;margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;;font-size:10pt;">&nbsp;</p>
<p style="text-align:center;margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">SIGNATURES </p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:0%;white-space:nowrap">
<p style="margin-top:12pt;margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></p></td>
<td valign="top">
<p style="margin-top:12pt;margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;">-2</a>-</p></td></tr></table></div>
<hr style="page-break-after:always;width:100%;">
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:7.14%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU3"></a><font style="font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </font></p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-size:12pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<div align="right">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:41.65%;">
<tr>
<td style="width:4.06%;"></td>
<td style="width:1.74%;"></td>
<td style="width:35.85%;"></td>
</tr>
<tr>
<td valign="middle"  style="padding-Top:0pt;padding-Bottom:0pt;">
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;text-align:left;">&nbsp;</p></td>
<td valign="middle"  style="padding-Top:0pt;padding-Bottom:0pt;">
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;text-align:left;">&nbsp;</p></td>
<td valign="middle"  style="padding-Top:0pt;padding-Bottom:0pt;">
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;font-size:12pt;text-align:left;">&nbsp;</p></td>
</tr>
<tr>
<td valign="middle"  style="padding-Top:0pt;padding-Bottom:0pt;">
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  style="padding-Top:0pt;padding-Bottom:0pt;">
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="middle"  style="padding-Top:0pt;padding-Bottom:0pt;">
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top"  style="padding-Top:0pt;padding-Bottom:0pt;">
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  style="padding-Top:0pt;padding-Bottom:0pt;">
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  style="padding-Top:0pt;padding-Bottom:0pt;">
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">IRIDEX CORPORATION</p></td>
</tr>
<tr style="height:12pt;">
<td valign="middle"  style="padding-Top:0pt;padding-Bottom:0pt;">
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td colspan="2" valign="middle"  style="padding-Top:0pt;padding-Bottom:0pt;">
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
</tr>
<tr>
<td valign="top"  style="padding-Top:0pt;padding-Bottom:0pt;">
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:</p></td>
<td valign="bottom"  style="padding-Top:0pt;padding-Bottom:0pt;">
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  style="padding-Top:0pt;padding-Bottom:0pt;">
<p style="margin-bottom:1pt;margin-top:0pt;border-bottom:Solid 0.75pt #000000;padding-bottom:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ William M. Moore</p></td>
</tr>
<tr>
<td valign="top"  style="padding-Top:0pt;padding-Bottom:0pt;">
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  style="padding-Top:0pt;padding-Bottom:0pt;">
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom"  style="padding-Top:0pt;padding-Bottom:0pt;">
<p style="margin-top:0pt;margin-bottom:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">William M. Moore</p>
<p style="margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;text-align:left;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">President and Chief Executive Officer</p></td>
</tr>
</table></div>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Date: April 29, 2019 </p>
<p style="margin-top:0pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Arial;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:0%;white-space:nowrap">
<p style="margin-top:12pt;margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"></p></td>
<td valign="top">
<p style="margin-top:12pt;margin-top:0pt;margin-bottom:0pt;text-indent:0%;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:11pt;">-3</a>-</p></td></tr></table></div></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>irix-ex991_7.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
<head>
<title>
irix-ex991_7.htm
</title>
</head>
<!-- NG Converter v5.0.19114.148 -->
<body>

<p style="text-align:right;margin-bottom:10pt;margin-top:0pt;text-indent:0%;font-family:Calibri;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exhibit 99.1</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:10pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Calibri;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;"><img src="goofnjshrd41000001.jpg" title="" alt="" style="width:96px;height:92px;"></p>
<p style="margin-bottom:10pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-family:Calibri;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">For Immediate Release</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:10pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:14pt;font-family:Calibri;font-style:normal;text-transform:none;font-variant: normal;">Scott Shuda Appointed to IRIDEX Board of Directors</p>
<p style="margin-bottom:10pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Calibri;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">Mountain View, Calif. April 29, 2019<font style="font-weight:normal;"> -- IRIDEX Corporation (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal diseases, announced today that Scott Shuda has been appointed to its board of directors, effective April 23, 2019.&nbsp;&nbsp;In connection with Shuda&#8217;s appointment, the size of the IRIDEX board was increased from seven to eight members. </font></p>
<p style="margin-bottom:10pt;margin-top:0pt;text-indent:0%;font-family:Calibri;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;Scott has extensive experience in the medical device industry, and we welcome him to the IRIDEX board. His background includes more than 20 years of experience in law, technology and entrepreneurial endeavors in the industry, including transactions that range from initial public offerings and venture financings to mergers and acquisitions.&nbsp;&nbsp;His insight, skills and <font style="color:#000000;">executive leadership experience are very complementary to our team</font>,&#8221; said William M. Moore, Chairman and Chief Executive Officer.</p>
<p style="margin-bottom:10pt;margin-top:0pt;text-indent:0%;font-family:Calibri;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Shuda has served as a member of the board of directors of InfuSystem Holdings, Inc., a provider of ambulatory infusion pumps, since September 2016, and was elected Chairman in December 2018. He is a Managing Director and Co-founder of Meridian OHC Partners, LP and BlueLine Partners, LLC, investment firms that focus on publicly listed technology and healthcare companies. Shuda previously served on the IRIDEX board from December 2012 to April 2017.</p>
<p style="margin-bottom:10pt;margin-top:0pt;text-indent:0%;font-family:Calibri;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On his appointment, Shuda commented, &#8220;It is very exciting to see the progress that IRIDEX has made in bringing to market a superior technology for the treatment of sight-threatening diseases. The growing evidence supporting the greatly improved patient outcomes with the use of the company&#8217;s Cyclo G6 platform is a true differentiator, and I look forward to helping the company continue to advance commercialization and grow market share.&#8221;</p>
<p style="margin-bottom:10pt;margin-top:0pt;text-indent:0%;font-family:Calibri;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Mr. Shuda holds both a Juris Doctor and a Master of Business Administration degree from Georgetown University.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#333333;font-family:Calibri;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">About&#160;IRIDEX</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#333333;font-family:Calibri;font-size:11pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">IRIDEX is a worldwide leader in developing innovative and versatile laser-based medical systems, delivery devices and consumable instrumentation for the ophthalmology market. The Company&#8217;s proprietary MicroPulse&#174; technology delivers a differentiated treatment that provides safe, effective, and proven treatment for targeted sight-threatening eye conditions.&#160;IRIDEX&#8217;s current product line is used for the treatment of glaucoma, diabetic macular edema (DME) and other retinal diseases. IRIDEX products are sold in&#160;the United States and Germany through a direct sales force and in more than 100 countries through a network of independent distributors. For more information, visit <font style="text-decoration:underline;color:#000000;">http://www.iridex.com</font><font style="color:#06A0CF;">.</font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:10pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Calibri;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;"><a name="_AEIOULastRenderedPageBreakAEIOU2"></a><font style="font-weight:bold;font-family:Calibri;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">Investor Relations Contact:</font><font style="font-weight:normal;"><br />Leigh Salvo</font><font style="font-weight:normal;"><br />(415) 937-5404</font><font style="font-weight:normal;"><br />investors@iridex.com</font></p>
<p style="margin-bottom:10pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Calibri;font-size:11pt;font-style:normal;text-transform:none;font-variant: normal;">Media Contact:<font style="font-weight:normal;"><br />Jamie Hall <br />Pascale Communications, LLC.<br />(724) 417-0167<br />pr@iridex.com</font></p></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>goofnjshrd41000001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 goofnjshrd41000001.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_X0""17AI9@  34T *@    @ ! $:  4
M   !    /@$;  4    !    1@$H  ,    !  (  (=I  0    !    3@
M      #<     0   -P    !  .@ 0 #     0 !  "@ @ $     0   -R@
M P $     0   -,       #_VP!#  $! 0$! 0(! 0(" @(" @," @(" P0#
M P,# P0%! 0$! 0$!04%!04%!04&!@8&!@8'!P<'!P@(" @(" @(" C_VP!#
M 0$! 0(" @," @,(!04%" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(
M" @(" @(" @(" @(" @(" @(" C_P  1" #3 -P# 2(  A$! Q$!_\0 'P
M 04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%! 0
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M22 )$$ ,CD8+DG^M;0M/L-)T>VTK2H8K:UM84MK:WA4)'%%$-B(B@ !54
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M^G#1*_H,K^?/_@L__P G2_LB?]E1F_\ 3AHE>IPY_O+_ ,%3_P!-R/(XH?\
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M^UD^6-_B>WZMOR2;ZV/[^Q>8TZ4_9).4[7Y5O;SZ)=G)I/9,_1_]N+_@LG\
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MLSPJ/#OQIT=9;R"-8]-\2:<([?6]/ E68K;7FQF$;LO[R)P\3@D,A!-?Q/\
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M7O$U]#+<)%HEK(9VM?D23=<ZF8VBAC*Y90[ -MVG_14_X(T_"#QSX^B\6?\
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MXCU*Y^W:C##< QS)91+'%##(8S\L[^<5).(E8*X_G,6-(@%B544<*B#:JCL
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MV;QSI-MKL2KM%QC[+-D*,9DA5HST)/[O.3U&,5_J,ZQ_P28\2_ _Q%=^*O\
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M76GP\\.1ZO?7>J2FVLO#/AFVEDFN2V9-@MK4-),55<_O"<!23@9-?L/\(/\
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M%B^U[PX_B.[\5^(_#-Z]QIEYIL.M:E*[BS=+B2*:*W>X@C5"(W92S ?*%/\
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MN]<]10:=$?S4^"[FVL?%NE7UZZQPP:E:2S2.?E1$E5F8^P -?ZP[_P#!=_\
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MMX4T;0/#NH1W=[<7>M6[6*,L:;L)#YWG2,< (AYR17^8/<#$AQG'OQ0:P/\
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ML5_\&JOQ \$^.+62Q\3>*M!B\?\ B&SFWB2"XUG4].^SPR([-Y<D5E%;QR(
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M6^^?]S_"@E%,'+9/K6A*[(0RGDC)SSU^N:SAU'UJ_<?P_P"[0$MC^\K]B?\
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;[L>E.E1?,/U]:9#W_P ]C4LO^L;ZTPF]#__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
